MeiraGTx Announces the Presentation of Two Novel Inherited Retinal Disease (IRD) Programs and…
Three Poster Presentations Highlight Versatility and Novelty of MeiraGTx’s Gene Therapy Development Platforms Novel Synthetic Riboswitch Platform Reversibly Regulates Gene Expression to High Dynamic Range and Drives Precise Dose…